Peer Review reports
From: Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
| Original Submission | ||
|---|---|---|
| 15 Dec 2022 | Submitted | Original manuscript |
| 9 Apr 2023 | Reviewed | Reviewer Report |
| 13 Apr 2023 | Reviewed | Reviewer Report |
| 30 May 2023 | Reviewed | Reviewer Report |
| 26 Jun 2023 | Author responded | Author comments - Qinfang Li |
| Resubmission - Version 2 | ||
| 26 Jun 2023 | Submitted | Manuscript version 2 |
| 5 Jul 2023 | Author responded | Author comments - Qinfang Li |
| Resubmission - Version 3 | ||
| 5 Jul 2023 | Submitted | Manuscript version 3 |
| 10 Jul 2023 | Author responded | Author comments - Qinfang Li |
| Resubmission - Version 4 | ||
| 10 Jul 2023 | Submitted | Manuscript version 4 |
| 21 Jul 2023 | Reviewed | Reviewer Report |
| 25 Jul 2023 | Reviewed | Reviewer Report |
| 2 Aug 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 2 Aug 2023 | Editorially accepted | |
| 11 Aug 2023 | Article published | 10.1186/s12876-023-02911-3 |
You can find further information about peer review here.